182 related articles for article (PubMed ID: 34272582)
1. Improving clinical utility of GAD65 autoantibodies by electrochemiluminescence assay and clinical phenotype when identifying autoimmune adult-onset diabetes.
Gu Y; Jia X; Vartak T; Miao D; Dong F; Jerram ST; Rewers M; Ferrara A; Lawrence JM; Yu L; Leslie RD;
Diabetologia; 2021 Sep; 64(9):2052-2060. PubMed ID: 34272582
[TBL] [Abstract][Full Text] [Related]
2. Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function.
Zhu Y; Qian L; Liu Q; Zou J; Zhou Y; Yang T; Huang G; Zhou Z; Liu Y
Diabetes Metab J; 2020 Apr; 44(2):260-266. PubMed ID: 31769235
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: Action LADA 12.
Achenbach P; Hawa MI; Krause S; Lampasona V; Jerram ST; Williams AJK; Bonifacio E; Ziegler AG; Leslie RD;
Diabetologia; 2018 Jul; 61(7):1644-1649. PubMed ID: 29619531
[TBL] [Abstract][Full Text] [Related]
4. Association of High-Affinity Autoantibodies With Type 1 Diabetes High-Risk HLA Haplotypes.
Triolo TM; Pyle L; Broncucia H; Armstrong T; Yu L; Gottlieb PA; Steck AK
J Clin Endocrinol Metab; 2022 Mar; 107(4):e1510-e1517. PubMed ID: 34850014
[TBL] [Abstract][Full Text] [Related]
5. Electrochemiluminescence assays for insulin and glutamic acid decarboxylase autoantibodies improve prediction of type 1 diabetes risk.
Miao D; Steck AK; Zhang L; Guyer KM; Jiang L; Armstrong T; Muller SM; Krischer J; Rewers M; Yu L;
Diabetes Technol Ther; 2015 Feb; 17(2):119-27. PubMed ID: 25562486
[TBL] [Abstract][Full Text] [Related]
6. Combined Detection of Islet Autoantibodies for Clinical Diagnosis of Type 1 Diabetes in the Low-Prevalence Population.
Qi Y; Chen S; Chen H; Chen Y; Shi Y; Qin Y; Zhang M; Yang T; Gu Y
J Clin Endocrinol Metab; 2023 May; 108(6):e326-e333. PubMed ID: 36480302
[TBL] [Abstract][Full Text] [Related]
7. GAD65 autoantibodies detected by electrochemiluminescence assay identify high risk for type 1 diabetes.
Miao D; Guyer KM; Dong F; Jiang L; Steck AK; Rewers M; Eisenbarth GS; Yu L
Diabetes; 2013 Dec; 62(12):4174-8. PubMed ID: 23974918
[TBL] [Abstract][Full Text] [Related]
8. The Use of Electrochemiluminescence Assays to Predict Autoantibody and Glycemic Progression Toward Type 1 Diabetes in Individuals with Single Autoantibodies.
Sosenko JM; Yu L; Skyler JS; Krischer JP; Gottlieb PA; Boulware D; Miao D; Palmer JP; Steck AK
Diabetes Technol Ther; 2017 Mar; 19(3):183-187. PubMed ID: 28177779
[TBL] [Abstract][Full Text] [Related]
9. Diabetes mellitus among young adults in Sri Lanka--role of GAD antibodies in classification and treatment: the Sri Lanka Young Diabetes study.
Katulanda P; Shine B; Katulanda GW; Silva A; Asfir EL; Sheriff R; Somasundaram N; Long AE; Bingley PJ; McCarthy MI; Clark A; Matthews DR
Diabetologia; 2008 Aug; 51(8):1368-74. PubMed ID: 18528678
[TBL] [Abstract][Full Text] [Related]
10. High-affinity ZnT8 Autoantibodies by Electrochemiluminescence Assay Improve Risk Prediction for Type 1 Diabetes.
Jia X; He L; Miao D; Waugh K; Rasmussen CG; Dong F; Steck AK; Rewers M; Yu L
J Clin Endocrinol Metab; 2021 Nov; 106(12):3455-3463. PubMed ID: 34343303
[TBL] [Abstract][Full Text] [Related]
11. Multiplex agglutination-PCR (ADAP) autoantibody assays compared to radiobinding autoantibodies in type 1 diabetes and celiac disease.
Lind A; de Jesus Cortez F; Ramelius A; Bennet R; Robinson PV; Seftel D; Gebhart D; Tandel D; Maziarz M; Agardh D; Larsson HE; Lundgren M; Tsai CT; Lernmark Å
J Immunol Methods; 2022 Jul; 506():113265. PubMed ID: 35358496
[TBL] [Abstract][Full Text] [Related]
12. International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice.
Bonifacio E; Atkinson M; Eisenbarth G; Serreze D; Kay TW; Lee-Chan E; Singh B
Diabetes; 2001 Nov; 50(11):2451-8. PubMed ID: 11679421
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of two nonisotopic immunoassays for determination of glutamic acid decarboxylase and tyrosine phosphatase autoantibodies in serum.
Palomer X; Mauricio D; Rodríguez-Espinosa J; Zapico E; Mayoral C; González-Sastre F; de Leiva A; Blanco-Vaca F
Clin Chem; 2004 Aug; 50(8):1378-82. PubMed ID: 15155543
[TBL] [Abstract][Full Text] [Related]
14. Islet Autoantibody Detection by Electrochemiluminescence (ECL) Assay.
Yu L
Methods Mol Biol; 2016; 1433():85-91. PubMed ID: 26659802
[TBL] [Abstract][Full Text] [Related]
15. Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes.
Giannopoulou EZ; Winkler C; Chmiel R; Matzke C; Scholz M; Beyerlein A; Achenbach P; Bonifacio E; Ziegler AG
Diabetologia; 2015 Oct; 58(10):2317-23. PubMed ID: 26138334
[TBL] [Abstract][Full Text] [Related]
16. ECL-IAA and ECL-GADA Can Identify High-Risk Single Autoantibody-Positive Relatives in the TrialNet Pathway to Prevention Study.
Steck AK; Fouts A; Miao D; Zhao Z; Dong F; Sosenko J; Gottlieb P; Rewers MJ; Yu L;
Diabetes Technol Ther; 2016 Jul; 18(7):410-4. PubMed ID: 26991969
[TBL] [Abstract][Full Text] [Related]
17. GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77.
Desai M; Cull CA; Horton VA; Christie MR; Bonifacio E; Lampasona V; Bingley PJ; Levy JC; Mackay IR; Zimmet P; Holman RR; Clark A
Diabetologia; 2007 Oct; 50(10):2052-60. PubMed ID: 17657474
[TBL] [Abstract][Full Text] [Related]
18. Glutamic acid decarboxylase 65 autoantibody levels discriminate two subtypes of latent autoimmune diabetes in adults.
Li X; Yang L; Zhou Z; Huang G; Yan X
Chin Med J (Engl); 2003 Nov; 116(11):1728-32. PubMed ID: 14642146
[TBL] [Abstract][Full Text] [Related]
19. Do Electrochemiluminescence Assays Improve Prediction of Time to Type 1 Diabetes in Autoantibody-Positive TrialNet Subjects?
Fouts A; Pyle L; Yu L; Miao D; Michels A; Krischer J; Sosenko J; Gottlieb P; Steck AK;
Diabetes Care; 2016 Oct; 39(10):1738-44. PubMed ID: 27456836
[TBL] [Abstract][Full Text] [Related]
20. High-Throughput Multiplex Electrochemiluminescence Assay Applicable to General Population Screening for Type 1 Diabetes and Celiac Disease.
He L; Jia X; Rasmussen CG; Waugh K; Miao D; Dong F; Frohnert B; Steck AK; Simmons KM; Rewers M; Yu L
Diabetes Technol Ther; 2022 Jul; 24(7):502-509. PubMed ID: 35238620
[No Abstract] [Full Text] [Related]
[Next] [New Search]
